Two local companies have secured $400K in funding to commercialize technologies licensed from U.S. military branches. Here ...
Inertia has signed three agreements with the Lawrence Livermore National Lab, paving the way for the company to bring its pioneering fusion reactor to market.
BioLineRx Ltd. (BLRX), a commercial-stage biopharmaceutical company, and Ayrmid Ltd., the parent company of Gamida Cell Ltd (GMDA), have entered into an exclusive license agreement to commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results